Signaling and transcriptional control of Fas ligand gene expression

M M Kavurma1, L M Khachigian

  • 1Centre for Thrombosis and Vascular Research, Department of Pathology, The University of New South Wales, Sydney, Australia.

Insights

Fas ligand (FasL) triggers apoptosis by activating caspases. Nuclear factors regulate FasL gene expression transcriptionally, impacting cellular degradation and death, particularly in diseases like atherosclerosis.

Area of Science:

  • Molecular Biology
  • Immunology
  • Cellular Biology

Background:

  • Fas ligand (FasL), a tumor necrosis factor family member, initiates apoptosis through Fas receptor binding.
  • Apoptosis involves sequential caspase activation, mitochondrial cytochrome c release, and cellular degradation.
  • Understanding FasL's role is crucial in diseases involving programmed cell death.

Purpose of the Study:

  • To review recent advances in understanding the molecular mechanisms controlling FasL gene expression.
  • To elucidate the transcriptional regulation of FasL.
  • To highlight the role of nuclear factors in FasL expression.

Main Methods:

  • Review of existing literature on FasL gene expression and regulation.
  • Analysis of studies identifying nuclear factors involved in FasL transcription.
  • Examination of the coexpression of FasL and regulatory factors in pathophysiological settings.

Main Results:

  • Multiple nuclear factors, including NFAT, NF-κB, Sp1, EGR, IRF, c-Myc, and FOX, activate FasL expression.
  • These factors can act alone or cooperatively to modulate FasL transcription.
  • Coexpression of these factors with FasL is observed in disease states such as human atherosclerotic lesions.

Conclusions:

  • FasL gene expression is tightly controlled at the transcriptional level by a network of nuclear factors.
  • These regulatory mechanisms are relevant to pathophysiological conditions, including atherosclerosis.
  • Further research into these signaling and transcriptional pathways is warranted.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...